SEI INVESTMENTS CO - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q1 2019$182,000
-1.1%
160,000
+4.6%
0.00%0.0%
Q4 2018$184,0000.0%153,0000.0%0.00%0.0%
Q3 2018$184,000
-45.1%
153,000
-45.9%
0.00%0.0%
Q2 2018$335,000
+7.4%
283,0000.0%0.00%0.0%
Q1 2018$312,000
+55.2%
283,000
+66.5%
0.00%0.0%
Q4 2017$201,000
+272.2%
170,000
+277.8%
0.00%
Q3 2017$54,0000.0%45,0000.0%0.00%
Q2 2017$54,000
+1.9%
45,0000.0%0.00%
Q1 2017$53,0000.0%45,0000.0%0.00%
Q4 2016$53,000
-5.4%
45,0000.0%0.00%
Q3 2016$56,000
+7.7%
45,0000.0%0.00%
Q2 2016$52,000
+10.6%
45,000
+28.6%
0.00%
Q4 2015$47,000
-50.0%
35,000
-50.0%
0.00%
-100.0%
Q3 2015$94,000
-15.3%
70,0000.0%0.00%0.0%
Q2 2015$111,000
+4.7%
70,0000.0%0.00%0.0%
Q1 2015$106,000
+23.3%
70,0000.0%0.00%0.0%
Q4 2014$86,00070,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q2 2019
NameSharesValueWeighting ↓
SCHRODER INVESTMENT MANAGEMENT GROUP 12,400,000$1,326,025,000,0001.66%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,000,000$8,643,0000.79%
OAKTREE CAPITAL MANAGEMENT LP 37,500,000$40,523,0000.74%
ADVENT CAPITAL MANAGEMENT /DE/ 46,800,000$50,350,0000.63%
Jabre Capital Partners S.A. 6,500,000$7,035,0000.54%
Nicholas Investment Partners, LP 6,470,000$6,919,0000.53%
Polar Asset Management Partners Inc. 10,000,000$10,788,0000.46%
AVIVA PLC 50,700,000$54,594,0000.46%
Man Investments (CH) AG 1,000,000$1,082,0000.44%
RWC Asset Management LLP 3,500,000$3,769,0000.40%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders